NIH-funded research R01 grant

Tiny synapse structures in autism and related conditions

Official title: Synaptic nanostructure and dysfunction in neurodevelopmental disorders

Funded at Vanderbilt University · NIH-11254905 · Data updated 2026-11-12

Researchers are mapping the tiny molecular machinery that helps brain cells talk to each other to understand how autism-linked changes disrupt that communication.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startDecember 1, 2023
Project endNovember 30, 2028
Funding year2026
Award (this year)$548,062
NIH project number5R01MH132918-03
Project IDNIH-11254905 on NIH RePORTER

Who could benefit from this research

Could help

Individuals diagnosed with autism spectrum disorder or related neurodevelopmental conditions could be relevant candidates if the project requests patient-derived cells, genetic samples, or clinical volunteers.

Less likely to help

People seeking immediate clinical treatment or symptom relief are unlikely to benefit directly because the project is focused on laboratory-based, foundational science.

What this research studies

This project maps the nanometer-scale arrangement of molecules that bridge two nerve cells (synapses) to learn how genetic changes tied to autism and related disorders alter communication. The team will use cryogenic electron tomography to make 3-D images of synapses, combine biochemical methods and mass spectrometry to identify the proteins involved, and use cell imaging plus electrophysiological recordings to link structure with function. Experiments will use lab models that include disease-linked genetic variants to build a detailed molecular blueprint of healthy and disrupted synapses. The investigators aim to connect specific molecular misarrangements to the communication problems seen in neurodevelopmental disorders.

Why it matters

Potential benefit: If successful, this work could point to molecular targets for new treatments and improve understanding of why symptoms arise in autism and related conditions.

How similar studies have gone: High-resolution imaging approaches like cryo-ET have successfully revealed synaptic structures in lab models before, but applying these techniques to autism-linked genetic variants is a relatively new direction.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Zhou, Qiangjun — Vanderbilt University
  • Study coordinator: Zhou, Qiangjun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.